The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive molecular characterization and analysis of muscle-invasive urothelial carcinomas.
 
Seth P. Lerner
Consulting or Advisory Role - BioCancell; Ferring; Nucleix; Sitka; Taris BioMedical; Telesta Therapeutics; Urogen pharma; Vaxiion
Research Funding - Endo Pharmaceuticals; FKD Therapies; JenaValve; Roche/Genentech; Viventia Biotech
Travel, Accommodations, Expenses - BioCancell; Ferring; Oncogenex; Urogen pharma
 
Gordon Robertson
No Relationships to Disclose
 
Jaegil Kim
No Relationships to Disclose
 
Andrew Cherniack
No Relationships to Disclose
 
Guangwu Guo
No Relationships to Disclose
 
Rehan Akbani
No Relationships to Disclose
 
Rupa S Kanchi
No Relationships to Disclose
 
Katherine A. Hoadley
No Relationships to Disclose
 
Toshinori Hinoue
No Relationships to Disclose
 
Peter W. Laird
No Relationships to Disclose
 
Hikmat Al-Ahmadie
No Relationships to Disclose
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Mauro Castro
No Relationships to Disclose
 
Dmitry Gordenin
No Relationships to Disclose
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; Immunome; Myriad Genetics; PTV Sciences; Spindletop Ventures
Honoraria - Allostery; AstraZeneca; Immunome; Isis Pharmaceuticals; Lilly; Novartis; Nuevolution; Symphony Evolution
Consulting or Advisory Role - Adventis Health; Allostery; AstraZeneca; Catena; Critical Outcome Technologies; Isis Pharmaceuticals; Lilly; MedImmune; Millennium; Novartis; Nuevolution; Precision Medicine Research Associates, LLC; Provista Diagnostics; SignalChem; Symphony Evolution; Tarveda Therapeutics; Tau Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; Critical Outcome Technologies; Illumina; Karus Therapeutics; Komipharm; Millennium; NanoString Technologies
Patents, Royalties, Other Intellectual Property - HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - Allostery; AstraZeneca; Immunome; Isis Pharmaceuticals; Lilly; MedImmune; Novartis; Pfizer; Symphony Evolution
 
Francisco Sanchez-Vega
No Relationships to Disclose
 
Sachet A Shukla
No Relationships to Disclose
 
Ewan A Gibb
No Relationships to Disclose
 
John N. Weinstein
No Relationships to Disclose
 
David J. Kwiatkowski
Consulting or Advisory Role - AstraZeneca
Research Funding - AADi